SEC Form 4 · accession 0000719135-17-000046
Apyx Medical Corp · APYX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lawrence Waldman
Director
Period of report
Sep 14, 2017
Accepted (ET)
Sep 27, 2017 · 9:03 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000719135
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Option to Buy)F1 | $2.85 | Sep 14, 2017 | A | 12,000 | A | Sep 14, 2018 | Sep 13, 2027 | Common Stock | 12,000 | 12,000 | D |
Explanation of responses
- F1Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.